Brant A. Inman MD, MSCary N. Robertson Associate Professor and Co-Director, Center of Prostate and Urologic Cancers, Duke Cancer Institute of Duke University, Durham, North Carolina
Brant A. Inman, MD, MS is Cary N. Robertson Associate Professor and Co-Director of the Center of Prostate and Urologic Cancers at the Duke Cancer Institute of Duke University. His area of clinical expertise is the surgical treatment of genitourinary cancers, with a particular emphasis on bladder cancer and advanced malignancies. From a research standpoint, Dr. Inman has a translational laboratory that is focused on novel therapies and diagnostic tests for genitourinary cancer as relates to immunotherapy and heat targeted therapies. He is principal investigator on several clinical trials of new therapies for urologic cancers.
Dr. Inman is a member of Board of Directors of the Society of Urologic Oncology Clinical Trials Consortium, a member of the National Comprehensive Cancer Network bladder cancer panel, a member of the Research Council and Research Grants and Investigator Support Committee of the American Urological Association, and Associate Editor of European Urology Focus.
Recent Contributions to PracticeUpdate:
- Repeat Transurethral Resection of MIBC Before Radical Cystectomy Is Prognostic but Not Therapeutic
- BCG Therapy Downregulates HLA-I on Malignant Cells to Subvert Antitumor Immune Responses in Bladder Cancer
- Somatic Mutations and Non–Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin Immunotherapy
- Outcomes Associated With Variant Histology Bladder Cancers Managed by Cystectomy With or Without Neoadjuvant Chemotherapy